Diagnostic value of miR-30d-5p and miR-125b-5p in acute myocardial infarction

Molecular Medicine Reports

Volumn 14, Issue 1, 2016, Pages 184-194

  Jia, Kegang ^a   Shi, Ping ^a   Han, Xuejing ^a   Chen, Tienan ^a   Tang, Hongxia ^a   Wang, Jing ^a  

^a TEDA INTERNATIONAL CARDIOVASCULAR HOSPITAL   (China)

Author keywords

Acute myocardial infarction; Diagnosis; Microarrays; MiR 125b 5p; MiR 30d 5p; Prognosis

Indexed keywords

CREATINE KINASE MB; HSA MICRORNA 101 3P; HSA MICRORNA 124 3P; HSA MICRORNA 125A 5P; HSA MICRORNA 125B 5P; HSA MICRORNA 129 1 3P; HSA MICRORNA 129 5P; HSA MICRORNA 132 5P; HSA MICRORNA 138 2 3P; HSA MICRORNA 138 5P; HSA MICRORNA 139 5P; HSA MICRORNA 149 5P; HSA MICRORNA 212 3P; HSA MICRORNA 22 3P; HSA MICRORNA 24 3P; HSA MICRORNA 29A 5P; HSA MICRORNA 29B 1 5P; HSA MICRORNA 29C 5P; HSA MICRORNA 30D 5P; HSA MICRORNA 330 5P; HSA MICRORNA 34C 5P; HSA MICRORNA 9 5P; MICRORNA; MICRORNA 125B 5P; MICRORNA 30D 5P; MICRORNA HSA LET 7B 5P; MICRORNA HSA LET 7G 5P; MICRORNA HSA LET 7I 5P; MYOGLOBIN; TROPONIN I; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN125 MICRORNA, HUMAN; MIRN30 MICRORNA, HUMAN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CIRCULATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; AGED; BLOOD; CASE CONTROL STUDY; CLUSTER ANALYSIS; COMORBIDITY; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MYOCARDIAL INFARCTION; PHENOTYPE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COMORBIDITY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; PHENOTYPE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84973509185     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5246     Document Type: Article

References (29)

1. Kumar A and Cannon CP: Acute coronary syndromes: Diagnosis and management, part I. Mayo Clin Proc 84: 917-938, 2009.
2. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE, 2nd, Fesmire FM, Hochman JS, Levin TN, et al: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction. J Am Coll Cardiol 50: e1-e157, 2007.
3. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, Fesmire FM, Ganiats TG, Lincoff AM, et al: 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update. Circulation 126: 875-910, 2012.
4. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats G, Holmes DR, Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, et al: 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes J Am Coll Cardiol 64: e139-228, 2014.
5. Braunwald E: Unstable angina and non-ST elevation myocardial infarction. Am J Respir Crit Care Med 185: 924-932, 2012.
6. White HD and Chew DP: Acute myocardial infarction. Lancet 372: 570-584, 2008.
7. Chieffo A, Buchanan GL, Mauri F, Mehilli J, Vaquerizo B, Moynagh A, Mehran R and Morice MC: ACS and STEMI treatment: Gender-related issues. EuroIntervention 8 (Suppl P): P27-P35, 2012.
8. Bellbhudder U and Stanfliet JC: Clinicians ignore best practice guidelines: Prospective audit of cardiac injury marker ordering in patients with chest pain. S Afr Med J 104: 305-306, 2014.
9. Ozturk G, Tavil B, Ozguner M, Ginis Z, Erden G, Tunc B, Azik MF, Uckan D and Delibas N: Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation. J Clin Lab Anal 29:259-262, 2015.
10. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M and Katus H: It's time for a change to a troponin standard. Circulation 102: 1216-1220, 2000.
11. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, et al; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators: A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 361: 2538-2547, 2009.
12. Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, Gilson G, Corsten MF, Schroen B, Lair ML, Heymans S and Wagner DR: Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 58: 559-567, 2012.
13. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Fröhlich M, et al: Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 361: 868-877, 2009.
14. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW and Jing Q: Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31: 659-666, 2010.
15. Hsu A, Chen SJ, Chang YS, Chen HC and Chu PH: Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction. BioMed Res Int 2014: 418628, 2014.
16. Peng L, Chun-guang Q, Bei-fang L, Xue-zhi D, Zi-hao W, Yun-fu L, Yan-ping D, Yang-gui L, Wei-guo L, Tian-yong H and Zhen-wen H: Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction. Diagn Pathol 9: 89, 2014.
17. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, et al: Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694, 2008.
18. Hu SJ, Ren G, Liu JL, Zhao ZA, Yu YS, Su RW, Ma XH, Ni H, Lei W and Yang ZM: MicroRNA expression and regulation in mouse uterus during embryo implantation. J Biol Chem 283: 23473-23484, 2008.
19. Dweep H and Gretz N: miRWalk2.0: A comprehensive atlas of microRNA-target interactions. Nat Methods 12: 697, 2015.
20. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008.
21. Fichtlscherer S1, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, et al: Circulating microRNAs in patients with coronary artery disease. Circ Res 107: 677-684, 2010.
22. Kroh EM, Parkin RK, Mitchell PS and Tewari M: Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301, 2010.
23. Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Just S, Borries A, Rudloff J, Leidinger P, et al: MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 106: 13-23, 2011.
24. Bostjancic E, Zidar N and Glavac D: MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers 27: 255-268, 2009.
25. Iguchi H, Kosaka N and Ochiya T: Secretory microRNAs as a versatile communication tool. Commun Integr Biol 3: 478-481, 2010.
26. Zampetaki A, Willeit P, Drozdov I, Kiechl S and Mayr M: Profiling of circulating microRNAs: From single biomarkers to re-wired networks. Cardiovasc Res 93: 555-562, 2012.
27. Gidlöf O, Andersson P, van der Pals J, Götberg M and Erlinge D: Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118: 217-226, 2011.
28. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659, 2007.
29. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh MN, Lutgens E, et al: Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2: ra81, 2009.